CHINA PHARMA HOLDINGS, INC. Long-term Line of Credit, Noncurrent
CHINA PHARMA HOLDINGS, INC. (CPHI) had Long-term Line of Credit, Noncurrent of $1.32 million as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLineOfCredit · last filed 2026-04-01
- 2025-06-30: Long-term Line of Credit, Noncurrent $1.32M.
- 2025-03-31: Long-term Line of Credit, Noncurrent $1.39M.
- 2024-12-31: Long-term Line of Credit, Noncurrent $1.39M.
- 2024-09-30: Long-term Line of Credit, Noncurrent $1.43M.
| Period end | Long-term Line of Credit, Noncurrent |
|---|---|
| 2025-06-30 | $1.32M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.39M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.39M 10-K · filed 2026-04-01 |
| 2024-09-30 | $1.43M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.40M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $1.41M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.39M 10-Q · filed 2023-11-13 |
| 2021-06-30 | $325.07K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $852.19K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $904.23K 10-K · filed 2022-03-30 |
| 2020-09-30 | $939.78K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $706.26K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |